Cargando…
Risk Factors for Prognosis in Patients With Severely Decreased GFR
INTRODUCTION: Patients with chronic kidney disease (CKD) and estimated glomerular filtration rate (eGFR) <30 ml/min per 1.73 m(2) (corresponding to CKD stage G4+) comprise a minority of the overall CKD population but have the highest risk for adverse outcomes. Many CKD G4+ patients are older with...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976849/ https://www.ncbi.nlm.nih.gov/pubmed/29854970 http://dx.doi.org/10.1016/j.ekir.2018.01.002 |
_version_ | 1783327247250227200 |
---|---|
author | Evans, Marie Grams, Morgan E. Sang, Yingying Astor, Brad C. Blankestijn, Peter J. Brunskill, Nigel J. Collins, John F. Kalra, Philip A. Kovesdy, Csaba P. Levin, Adeera Mark, Patrick B. Moranne, Olivier Rao, Panduranga Rios, Pablo G. Schneider, Markus P. Shalev, Varda Zhang, Haitao Chang, Alex R. Gansevoort, Ron T. Matsushita, Kunihiro Zhang, Luxia Eckardt, Kai-Uwe Hemmelgarn, Brenda Wheeler, David C. |
author_facet | Evans, Marie Grams, Morgan E. Sang, Yingying Astor, Brad C. Blankestijn, Peter J. Brunskill, Nigel J. Collins, John F. Kalra, Philip A. Kovesdy, Csaba P. Levin, Adeera Mark, Patrick B. Moranne, Olivier Rao, Panduranga Rios, Pablo G. Schneider, Markus P. Shalev, Varda Zhang, Haitao Chang, Alex R. Gansevoort, Ron T. Matsushita, Kunihiro Zhang, Luxia Eckardt, Kai-Uwe Hemmelgarn, Brenda Wheeler, David C. |
author_sort | Evans, Marie |
collection | PubMed |
description | INTRODUCTION: Patients with chronic kidney disease (CKD) and estimated glomerular filtration rate (eGFR) <30 ml/min per 1.73 m(2) (corresponding to CKD stage G4+) comprise a minority of the overall CKD population but have the highest risk for adverse outcomes. Many CKD G4+ patients are older with multiple comorbidities, which may distort associations between risk factors and clinical outcomes. METHODS: We undertook a meta-analysis of risk factors for kidney failure treated with kidney replacement therapy (KRT), cardiovascular disease (CVD) events, and death in participants with CKD G4+ from 28 cohorts (n = 185,024) across the world who were part of the CKD Prognosis Consortium. RESULTS: In the fully adjusted meta-analysis, risk factors associated with KRT were time-varying CVD, male sex, black race, diabetes, lower eGFR, and higher albuminuria and systolic blood pressure. Age was associated with a lower risk of KRT (adjusted hazard ratio: 0.74; 95% confidence interval: 0.69–0.80) overall, and also in the subgroup of individuals younger than 65 years. The risk factors for CVD events included male sex, history of CVD, diabetes, lower eGFR, higher albuminuria, and the onset of KRT. Systolic blood pressure showed a U-shaped association with CVD events. Risk factors for mortality were similar to those for CVD events but also included smoking. Most risk factors had qualitatively consistent associations across cohorts. CONCLUSION: Traditional CVD risk factors are of prognostic value in individuals with an eGFR <30 ml/min per 1.73 m(2), although the risk estimates vary for kidney and CVD outcomes. These results should encourage interventional studies on correcting risk factors in this high-risk population. |
format | Online Article Text |
id | pubmed-5976849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-59768492018-05-31 Risk Factors for Prognosis in Patients With Severely Decreased GFR Evans, Marie Grams, Morgan E. Sang, Yingying Astor, Brad C. Blankestijn, Peter J. Brunskill, Nigel J. Collins, John F. Kalra, Philip A. Kovesdy, Csaba P. Levin, Adeera Mark, Patrick B. Moranne, Olivier Rao, Panduranga Rios, Pablo G. Schneider, Markus P. Shalev, Varda Zhang, Haitao Chang, Alex R. Gansevoort, Ron T. Matsushita, Kunihiro Zhang, Luxia Eckardt, Kai-Uwe Hemmelgarn, Brenda Wheeler, David C. Kidney Int Rep Clinical Research INTRODUCTION: Patients with chronic kidney disease (CKD) and estimated glomerular filtration rate (eGFR) <30 ml/min per 1.73 m(2) (corresponding to CKD stage G4+) comprise a minority of the overall CKD population but have the highest risk for adverse outcomes. Many CKD G4+ patients are older with multiple comorbidities, which may distort associations between risk factors and clinical outcomes. METHODS: We undertook a meta-analysis of risk factors for kidney failure treated with kidney replacement therapy (KRT), cardiovascular disease (CVD) events, and death in participants with CKD G4+ from 28 cohorts (n = 185,024) across the world who were part of the CKD Prognosis Consortium. RESULTS: In the fully adjusted meta-analysis, risk factors associated with KRT were time-varying CVD, male sex, black race, diabetes, lower eGFR, and higher albuminuria and systolic blood pressure. Age was associated with a lower risk of KRT (adjusted hazard ratio: 0.74; 95% confidence interval: 0.69–0.80) overall, and also in the subgroup of individuals younger than 65 years. The risk factors for CVD events included male sex, history of CVD, diabetes, lower eGFR, higher albuminuria, and the onset of KRT. Systolic blood pressure showed a U-shaped association with CVD events. Risk factors for mortality were similar to those for CVD events but also included smoking. Most risk factors had qualitatively consistent associations across cohorts. CONCLUSION: Traditional CVD risk factors are of prognostic value in individuals with an eGFR <30 ml/min per 1.73 m(2), although the risk estimates vary for kidney and CVD outcomes. These results should encourage interventional studies on correcting risk factors in this high-risk population. Elsevier 2018-01-11 /pmc/articles/PMC5976849/ /pubmed/29854970 http://dx.doi.org/10.1016/j.ekir.2018.01.002 Text en © 2018 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Clinical Research Evans, Marie Grams, Morgan E. Sang, Yingying Astor, Brad C. Blankestijn, Peter J. Brunskill, Nigel J. Collins, John F. Kalra, Philip A. Kovesdy, Csaba P. Levin, Adeera Mark, Patrick B. Moranne, Olivier Rao, Panduranga Rios, Pablo G. Schneider, Markus P. Shalev, Varda Zhang, Haitao Chang, Alex R. Gansevoort, Ron T. Matsushita, Kunihiro Zhang, Luxia Eckardt, Kai-Uwe Hemmelgarn, Brenda Wheeler, David C. Risk Factors for Prognosis in Patients With Severely Decreased GFR |
title | Risk Factors for Prognosis in Patients With Severely Decreased GFR |
title_full | Risk Factors for Prognosis in Patients With Severely Decreased GFR |
title_fullStr | Risk Factors for Prognosis in Patients With Severely Decreased GFR |
title_full_unstemmed | Risk Factors for Prognosis in Patients With Severely Decreased GFR |
title_short | Risk Factors for Prognosis in Patients With Severely Decreased GFR |
title_sort | risk factors for prognosis in patients with severely decreased gfr |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976849/ https://www.ncbi.nlm.nih.gov/pubmed/29854970 http://dx.doi.org/10.1016/j.ekir.2018.01.002 |
work_keys_str_mv | AT evansmarie riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT gramsmorgane riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT sangyingying riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT astorbradc riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT blankestijnpeterj riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT brunskillnigelj riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT collinsjohnf riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT kalraphilipa riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT kovesdycsabap riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT levinadeera riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT markpatrickb riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT moranneolivier riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT raopanduranga riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT riospablog riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT schneidermarkusp riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT shalevvarda riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT zhanghaitao riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT changalexr riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT gansevoortront riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT matsushitakunihiro riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT zhangluxia riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT eckardtkaiuwe riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT hemmelgarnbrenda riskfactorsforprognosisinpatientswithseverelydecreasedgfr AT wheelerdavidc riskfactorsforprognosisinpatientswithseverelydecreasedgfr |